Please login to the form below

Not currently logged in
Email:
Password:

propofol

This page shows the latest propofol news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca sells rights to seven anaesthetics in $770m deal

AstraZeneca sells rights to seven anaesthetics in $770m deal

topical anaesthetics Diprivan (propofol) and EMLA (lidocain and prilocaine), plus five local anaesthetics.

Latest news

  • R&D news in brief

    SkyePharma and Endo halt Propofol IDD-DTM development. SkyePharma says it has agreed with US partner Endo to terminate joint development of Propofol IDD-DTM, an injectable anaesthetic and sedative that ... Under the terms of the December 2002 agreement,

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Deal Watch June 2016 Deal Watch June 2016

    Paying $520m upfront Aspen gains access to a series of local anaesthetics including Marcaine (bupivacaine) and Xylocaine (lidocaine/ lignocaine), and Diprivan (propofol), a short acting intravenous sedative/ anaesthetic.

  • Pharma deals in February 2015 Pharma deals in February 2015

    The sedative and analgesic propofol recall on the very day the acquisition was announced due, and not for the first time, to particulate iron embedded in the neck of a vial

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcircle

We're Healthcircle – an award-winning healthcare advertising and creative communications agency, offering a holistic approach to brand health. With a...

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics